In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary...
You may have noticed that women are more prone to sleep disturbances than men. They are, for instance, up to twice as likely to suffer from insomnia than men. Could there be a link between the body...
By Vincent C. AllaireNewsroom
Human genome editing for both research and therapy is progressing, raising ethical questions among scientists around the world.